IDEXX Laboratories demonstrates a high-quality business model supported by strong financial performance, customer retention, and a robust innovation pipeline. However, the company faces challenges such as declining clinical visits and potential headwinds from customer agreements. Overall, the future prospects remain positive, bolstered by innovative product launches and strategic growth initiatives.
Analysis Date: February 3, 2025 Last Updated: May 29, 2025
+718%
+23.4% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryUS
ExchangeNASDAQ
IndustryMedical - Diagnostics & Research
SectorHealthcare
Market Cap$35.14B
CEOMr. Jonathan J. Mazelsky
IDEXX Laboratories, Inc. is a company that creates and sells products to help take care of animals and keep our water safe. They provide tools for veterinarians to test pets' health, like quick test kits and lab services. They also make products to check the health of farm animals and test water for harmful germs. Overall, IDEXX helps ensure that animals stay healthy and that our water is clean.
Streams of revenue
Product:58%
Service:42%
Geographic Distribution
UNITED STATES:65%
EMEA:20%
Asia Pacific:8%
CANADA:4%
Latin America:2%
Core Products
๐งช
SNAP TestsRapid tests
๐ง
Water TestingWater quality tests
๐ฌ
VetLab StationLab diagnostics
๐ป
Cornerstone SoftwarePractice management
๐
Livestock DiagnosticsAnimal health tests
Business Type
Business to Business
Competitive Advantages
Unlock Competitive Advantages Analysis
Discover all competitive advantages and strategic moats that protect IDXX's market position.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
๐
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
๐
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
IDXX Stock Analysis: IDEXX Laboratories, Inc. Investment Guide
IDXX (IDEXX Laboratories, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 23.4% annual returns with an overall investment score of None/100.
IDEXX Laboratories demonstrates a high-quality business model supported by strong financial performance, customer retention, and a robust innovation pipeline. However, the company faces challenges such as declining clinical visits and potential headwinds from customer agreements. Overall, the future prospects remain positive, bolstered by innovative product launches and strategic growth initiatives.
IDXX Key Financial Metrics
IDXX financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. and profitability score of 7.5/100 with financial health rated 6.7/100.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a company that creates and sells products to help take care of animals and keep our water safe. They provide tools for veterinarians to test pets' health, like quick test kits and lab services. They also make products to check the health of farm animals and test water for harmful germs. Overall, IDEXX helps ensure that animals stay healthy and that our water is clean.
IDXX Investment Recommendation
Based on our comprehensive analysis of IDXX, investors should consider the company's strong performance track record, earnings consistency (10/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
IDXX operates in the Medical - Diagnostics & Research industry within the Healthcare sector. This analysis compares IDEXX Laboratories, Inc. performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about IDXX Stock
Is IDXX a good investment?
IDXX (IDEXX Laboratories, Inc.) has generated 23.4% annual returns with an overall score of None/100. IDEXX Laboratories demonstrates a high-quality business model supported by strong financial performance, customer retention, and a robust innovation pipeline. However, the company faces challenges such as declining clinical visits and โฆ Investors should consider their risk tolerance and investment goals when evaluating IDXX.
What is IDXX P/E ratio and valuation?
IDXX valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Diagnostics & Research industry and Healthcare sector benchmarks.
Should I buy IDXX stock now?
The decision to buy IDXX stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 7.5/100, financial health score of 6.7/100, and detailed performance metrics to help inform your investment decision.
What are IDXX financial health indicators?
IDXX financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 6.7/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does IDXX compare to competitors?
IDXX performance is benchmarked against Medical - Diagnostics & Research industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for IDEXX Laboratories, Inc.'s market position.
What are IDXX historical returns?
IDXX has generated 23.4% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
IDXX Key Investment Metrics Summary
Annual Return: 23.4%
Profitability Score: 7.5/100
Financial Health Score: 6.7/100
Growth Score: -3.074015347047194/100
Earnings Beat Rate: 10/10 quarters
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: NASDAQ Global Select
Market Cap: 35141637852
IDXX Investment Thesis
IDEXX Laboratories, Inc. (IDXX) represents an excellent investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
High Return on Equity
Strong Profit Margins
Strong Interest Coverage
Strong Financial Performance
High Customer Retention
Innovative Product Portfolio
Optimistic 2025 Guidance
Expansion of Software Solutions
Investment Risks
High Price-to-Earnings Ratio
Elevated Price-to-Sales Ratio
Low Current and Quick Ratios
Pressure on Clinical Visits
Potential Headwinds from Customer Agreements
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.